BRISTOL MYERS SQUIBB CO (BMY) revenue & profit

BRISTOL MYERS SQUIBB CO (BMY): revenue $48.2B, net income $7.1B in 2025; latest quarter +5.7% year over year. From SEC filings.

$48.2BRevenue 2025

TickerBMY (NYSE)

IndustryHealthcare · Pharmaceutical Preparations

Revenue 2025$48.2B

Net income 2025$7.1B

Net margin14.6%

Annual revenue growth-0.2%

Latest quarter (2026 Q2) · Revenue$13B

vs. same quarter last year+5.7%

Latest quarter · Net income$3.3B

Annual revenue & net income

Year	Revenue	Net income
2022	$46.2B	$6.3B
2023	$45B	$8B
2024	$48.3B	-$8.9B
2025	$48.2B	$7.1B

ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.

↗ Official filings on SEC EDGAR

📷 Logo is a trademark of its owner · Bristol-Myers Squibb · Public domain · Wikimedia Commons

📷 Coolcaesar at English Wikipedia · CC BY-SA 3.0 · Wikimedia Commons

About this data

Figures come from the financial statements U.S.-listed companies file with the Securities and Exchange Commission (SEC EDGAR, XBRL data). We use reported annual and quarterly revenue and net income and compare them with the same period a year earlier to calculate growth.

Companies use different fiscal years and sometimes restate past results, and one-off items can make net income jump. This page is for information only and is not investment advice.